
The economics of the public option: Evidence from local pharmaceutical markets</a><br>
with Juan Pablo Atal, José Ignacio Cuesta, and Cristóbal Otero. <a href="https://www.nber.org/papers/w30779">NBER working paper</a><br>
revise and resubmit, <i>American Economic Review</i>
</li>
